A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Radiation Oncology Residency Program Bookmark and Share

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two  Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 

Radiation Oncology Residency Program

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two  Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • The connection between lifestyle and cancer is real. Knowing that, what can individuals do to lower their risk? City of Hope physicians recently came together to answer that precise question, explaining the links between cancer and the choices we make that affect our health. Moderator Vijay Trisal M.D., medical...
  • White button mushrooms seem fairly innocuous as fungi go. Unlike portabellas, they don’t center stage at the dinner table, and unlike truffles, they’re not the subject of gourmand fervor. But appearances can be deceiving when it comes to these mild-mannered Clark Kents of the food world. In a study ...
  • Doctors often recommend preventive screenings for several cancers, based on hereditary or genetic factors, but brain tumors aren’t one of them. Primary brain tumors, which originate in the brain rather than spreading from another location, seem to develop at random, and doctors have little insight into wh...
  • Stopping cancer starts with research. To that end, STOP CANCER has awarded $525,000 in grants to City of Hope for 2015, supporting innovative research projects and recognizing the institution’s leadership in advancing cancer treatment and prevention. Founded in 1988, STOP CANCER underwrites the work of le...
  • Cancer may not be the disease many people think it is. Normally, cancer is considered to be a disease in which cells multiply at an extremely high, and unusual, rate – increasing the likelihood of genetic mutations. But increasingly, leading researchers at City of Hope and elsewhere are contending that cancer i...
  • “Of all forms of inequality, injustice in the health care system is the most shocking and inhumane.” By the time the Rev. Martin Luther King Jr. spoke those words in Chicago in 1966, the Civil Rights Act had been passed, the Voting Rights Act was the law of the land and the March on Washington was […]
  • Eight years ago, Matthew Loscalzo surprised himself by accepting the offer to become City of Hope’s administrative director of the Sheri & Les Biller Patient and Family Resource Center and executive director of the Department of Supportive Care Medicine. At the time, he was administrative director of the Sc...
  • The mental fog that patients can experience after undergoing chemotherapy treatment for cancer has a name: “chemo brain.” “Many patients report hearing or reading about chemotherapy-related cognitive deficits, but few are actually prepared to deal with these changes,” said Celina Lemon, M.A., an occupational th...
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...